Hotline:
+ 49 (0) 2204 2918806

Market studies for category Pandemic Vaccines

Items 1 to 10 of 25 total

  1. 1
  2. | 2
  3. | 3
  1. Net price*
    Year
  2. $4,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis

    GlobalData
    112 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sal
    Englisch | Report | SKU: 329167
  3. $4,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis

    GlobalData
    55 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of pr
    Englisch | Report | SKU: 329178
  4. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Fluzone High-Dose - (Seasonal Influenza Vaccine) Forecast and Market Analysis

    GlobalData
    37 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluzone High-Dose - (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven b
    Englisch | Report | SKU: 329183
  5. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis

    GlobalData
    36 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “FluMist (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales
    Englisch | Report | SKU: 329188
  6. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

    GlobalData
    68 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of pr
    Englisch | Report | SKU: 329193
  7. $4,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis

    GlobalData
    83 pages
    Introduction GlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of pr
    Englisch | Report | SKU: 329174
  8. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis

    GlobalData
    55 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluzone IntraDermal (Seasonal Influenza Vaccines) Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven
    Englisch | Report | SKU: 329181
  9. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis

    GlobalData
    37 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales
    Englisch | Report | SKU: 329186
  10. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

    GlobalData
    37 pages
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis”. Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales
    Englisch | Report | SKU: 329191
  11. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

    GlobalData
    69 pages
    Introduction Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. Vaccination has been shown to reduce influenza morbidity and mortality and high economic burden associated with influenza illness. GlobalData’s epidemiologists expect seasonal influ
    Englisch | Report | SKU: 329209

Items 1 to 10 of 25 total

  1. 1
  2. | 2
  3. | 3